Allurion Technologies, Inc. (ALUR) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-03-31..
Quick ratio
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 37.26M USD | Liabilities, Current |
| Cash and equivalents | 5.06M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 3.48M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 2.06M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | (m) | $37.26M | $5.06M | (m) | $3.48M | $2.06M | (m) |
| 2025-12-31 | (m) | $38.45M | $5.41M | (m) | $3.95M | $2.67M | (m) |
| 2025-09-30 | (m) | $11.62M | $6.14M | (m) | $3.98M | $3.67M | (m) |
| 2025-06-30 | (m) | $11.62M | $12.72M | (m) | $5.85M | $3.77M | (m) |
| 2025-03-31 | (m) | $15.90M | $20.41M | (m) | $8.31M | $3.35M | (m) |
| 2024-12-31 | (m) | $18.86M | $15.38M | (m) | $7.13M | $3.40M | (m) |
| 2024-09-30 | (m) | $19.24M | $28.65M | (m) | $9.94M | $4.57M | (m) |
| 2024-06-30 | (m) | $23.56M | $19.26M | (m) | $13.36M | $4.79M | (m) |
| 2024-03-31 | (m) | $66.22M | $29.68M | (m) | $16.16M | $5.63M | (m) |
| 2023-12-31 | (m) | $65.42M | $38.04M | (m) | $18.19M | $6.17M | (m) |
| 2023-09-30 | (m) | $87.23M | $79.87M | (m) | $27.64M | $4.02M | (m) |
| 2023-06-30 | (m) | $89.89M | $4.74M | (m) | $25.56M | $4.86M | (m) |
| 2022-12-31 | (m) | $75.87M | $7.68M | (m) | $29.35M | $3.87M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |